Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 120 Records) |
| Query Trace: Recurrence and BRCA2[original query] |
|---|
| Prevalence of Pathogenic Germline BRCA1/2 Variants and Their Association with Clinical Characteristics in Patients with Epithelial Ovarian Cancer in a Rural Area of Japan. Genes 2022 6 13 (6): . Abe Akiko, Imoto Issei, Tange Shoichiro, Nishimura Masato, Iwasa Takes |
| A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN). In vivo (Athens, Greece) 2022 6 36 (4): 1949-1958. Lee Yong Jae, Seol Aeran, Lee Maria, Kim Jae-Weon, Kim Hee Seung, Kim Kidong, Suh Dong Hoon, Kim Sunghoon, Kim Sang Wun, Lee Jung-Y |
| Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy. Genes & genomics 2022 May . Huh Yeon-Ju, Cho Sung-Yup, Cho Min-Sun, Lee Kyoung-Eun, Lee Joo- |
| Enrichment of "Cribriform" morphologies (intraductal and cribriform adenocarcinoma) and genomic alterations in radiorecurrent prostate cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2022 5 35 (10): 1468-1474. Shah Rajal B, Palsgrove Doreen N, Desai Neil B, Gagan Jeffrey, Mennie Amanda, Raj Ganesh, Hannan Raquib |
| Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial. International journal of cancer 2022 May . Koole Simone N, Schouten Philip C, Hauke Jan, Kluin Roel J C, Nederlof Petra, Richters Lisa K, Krebsbach Gabriele, Sikorska Karolina, Alkemade Maartje, Opdam Mark, Schagen van Leeuwen Jules H, Schreuder Henk W R, Hermans Ralph H M, de Hingh Ignace H J T, Mom Constantijne H, Arts Henriette J G, van Ham Maaike, van Dam Peter, Vuylsteke Peter, Sanders Joyce, Horlings Hugo M, van de Vijver Koen K, Hahnen Eric, van Driel Willemien J, Schmutzler Rita, Sonke Gabe S, Linn Sabine |
| Germline mutations in penetrant cancer predisposition genes are rare in men with prostate cancer selecting active surveillance. Cancer medicine 2022 4 11 (22): 4332-4340. Brady Lauren, Newcomb Lisa F, Zhu Kehao, Zheng Yingye, Boyer Hilary, Sarkar Navonil De, McKenney Jesse K, Brooks James D, Carroll Peter R, Dash Atreya, Ellis William J, Filson Christopher P, Gleave Martin E, Liss Michael A, Martin Frances, Morgan Todd M, Thompson Ian M, Wagner Andrew A, Pritchard Colin C, Lin Daniel W, Nelson Peter |
| Clinicopathological features, genetic alterations, and BRCA1 promoter methylation in Japanese male patients with breast cancer. Breast cancer research and treatment 2022 12 197 (3): 593-602. Shimomura Akihiko, Yoshida Masayuki, Kubo Takashi, Yamashita Satoshi, Noguchi Emi, Nagayama Aiko, Hanamura Toru, Okazaki Miki, Mukohara Toru, Tsuruga Asako, Tanaka Kiyo, Kawamura Yukino, Higuchi Toru, Takahashi Yoko, Kurozumi Sasagu, Hayashida Tetsu, Ichikawa Hitoshi, Ushijima Toshikazu, Suto Akihi |
| The therapeutic relevance of a BRCA2 mutation in a patient with recurrent thymoma: a case report. Mediastinum (Hong Kong, China) 2022 12 6 40. Sigurdson Samantha, Marom Edith M, Rimner Andreas, Shepherd Annemarie, Szolkowska Malgorzata, Roden Anja C, Marino Mirella, Tomiyama Noriyuki, Ball David, Falkson Conrad, Rajan Ar |
| Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers. Nature communications 2022 11 13 (1): 6728. Shah Jennifer B, Pueschl Dana, Wubbenhorst Bradley, Fan Mengyao, Pluta John, D'Andrea Kurt, Hubert Anna P, Shilan Jake S, Zhou Wenting, Kraya Adam A, Llop Guevara Alba, Ruan Catherine, Serra Violeta, Balmaña Judith, Feldman Michael, Morin Pat J, Nayak Anupma, Maxwell Kara N, Domchek Susan M, Nathanson Katherine |
| Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients. European journal of breast health 2022 10 18 (4): 323-328. Do?an ?zzet, Ayd?n Esra, Yaz?c? Hülya, Saip P?n |
| BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making. Cancers 2022 Sep 14 (19): . Pavese Francesco, Capoluongo Ettore Domenico, Muratore Margherita, Minucci Angelo, Santonocito Concetta, Fuso Paola, Concolino Paola, Di Stasio Enrico, Carbognin Luisa, Tiberi Giordana, Garganese Giorgia, Corrado Giacomo, Di Leone Alba, Generali Daniele, Fragomeni Simona Maria, D'Angelo Tatiana, Franceschini Gianluca, Masetti Riccardo, Fabi Alessandra, Mulè Antonino, Santoro Angela, Belli Paolo, Tortora Giampaolo, Scambia Giovanni, Paris I |
| Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer. JAMA oncology 2023 9 . Burcu F Darst, Ed Saunders, Tokhir Dadaev, Xin Sheng, Peggy Wan, Loreall Pooler, Lucy Y Xia, Stephen Chanock, Sonja I Berndt, Ying Wang, Alpa V Patel, Demetrius Albanes, Stephanie J Weinstein, Vincent Gnanapragasam, Chad Huff, Fergus J Couch, Alicja Wolk, Graham G Giles, Tu Nguyen-Dumont, Roger L Milne, Mark M Pomerantz, Julie A Schmidt, Ruth C Travis, Timothy J Key, Konrad H Stopsack, Lorelei A Mucci, William J Catalona, Beth Marosy, Kurt N Hetrick, Kimberly F Doheny, Robert J MacInnis, Melissa C Southey, Rosalind A Eeles, Fredrik Wiklund, David V Conti, Zsofia Kote-Jarai, Christopher A Haim |
| Three cases of colon cancer in four generations of the Saudi family, caused by endogamous germline mutations. Cellular and molecular biology (Noisy-le-Grand, France) 2023 9 69 (8): 163-171. Dalal S Alshaya, Tahani Mohamed Ibrahim Al-Hazani, Mashael Alhumaidi Alotaibi, Dalia Mostafa Domiaty, Eman Alshehri, Maha Abdulla Alwaili, Amani Mohammed Alotaibi, Areej Saud Jalal, Alaa Ali AlQahtani, Fatima Abdullah AlQassim, Gadah Albasher, Wedad Saeed Al-Qahta |
| Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial). BMC cancer 2023 9 23 (1): 865. Sung-Hsin Kuo, Ling-Ming Tseng, Shou-Tung Chen, Yasuaki Sagara, Yuan-Ching Chang, Hsien-Tang Yeh, Yao-Lung Kuo, Chih-Chiang Hung, Tzu-Pin Lu, Yi-Hsuan Lee, Masakazu Toi, Chiun-Sheng Hua |
| Survival Outcomes and Efficacy of Platinum in Early Breast Cancer Patients with Germline BRCA1 or BRCA2 Mutation: A Multicenter Retrospective Cohort Study. Breast cancer (Dove Medical Press) 2023 9 15 671-682. Xi Chen, Xiaoyan Qian, Min Xiao, Pin Zha |
| A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer. Journal of cancer research and clinical oncology 2023 8 . Qiao-Yan Zhu, Pu-Chun Li, Yi-Fan Zhu, Jia-Ni Pan, Rong Wang, Xiao-Lin Li, Wei-Wu Ye, Xiao-Wen Ding, Xiao-Jia Wang, Wen-Ming C |
| Genomic analyses of germline and somatic variation in high-grade serous ovarian cancer. Journal of ovarian research 2023 7 16 (1): 141. A W Adamson, Y C Ding, L Steele, L A Leong, R Morgan, M T Wakabayashi, E S Han, T H Dellinger, P S Lin, A A Hakim, S Wilczynski, C D Warden, S Tao, V Bedell, M C Cristea, S L Neuhaus |
| Genomic Analyses of Germline and Somatic Variation in High-Grade Serous Ovarian Cancer. Research square 2023 3 . Adamson Aaron W, Ding Yuan Chun, Steele Linda, Leong Lucile A, Morgan Robert, Wakabayashi Mark T, Han Ernest S, Dellinger Thanh H, Lin Paul S, Hakim Amy A, Wilczynski Sharon, Warden Charles D, Tao Shu, Bedell Victoria, Cristea Mihaela C, Neuhausen Susan |
| Impact of multifocal or multicentric disease on local recurrence and survival in breast cancer patients with or without BRCA1/2 variants. Breast cancer research and treatment 2023 3 . Liu Xuejing, Wang Yanjie, Cao Kun, Yao Lu, Hu Li, Sun Jie, Zhang Juan, Xu Ye, Xie Yunt |
| Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation? Breast cancer (Dove Medical Press) 2023 2 15 163-173. Emiroglu Selman, Özkurt Enver, Cab?oglu Neslihan, Igci Abdullah, Saip Pinar, Yazici Hulya, Ozmen Tolga, Ozmen Vahit, Muslumanoglu Mahmut, Tukenmez Musta |
| Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer. Cancers 2023 12 15 (23): . Pedro Antunes Meireles, Sofia Fragoso, Teresa Duarte, Sidónia Santos, Catarina Bexiga, Priscila Nejo, Ana Luís, Beatriz Mira, Isália Miguel, Paula Rodrigues, Fátima V |
| Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
| Whole exome germline sequencing in early-onset prostate cancer patients: Genomic findings and clinical outcomes. The Prostate 2023 10 . Nava Siegelmann-Danieli, Victoria Neiman, Avital Bareket-Samish, Racheli Berger, Asaf Peretz, Hillel Alapi, Erez Tsur, Tal Patalon, Daniella Beller, Galit Rimler, Gabriel Chodick, Mordechai Shoh |
| The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer. Gland surgery 2023 1 11 (12): 1924-1935. Yang Yang, Zhang Jie, Li Jiao-Yang, Xu Lu, Wang Si-Ning, Zhang Jun-Qi, Xun Zhou, Xia Yu, Cao Jian-Bo, Liu Yang, Shi Li-Yan, Li Wei, Shi Yong-Lei, He Yuan-Ge, Gu De-Jian, Yu Zheng-Yuan, Chen Kai, Lan Ji |
| Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer. Cancer medicine 2023 1 . Nukaya Takuhisa, Sumitomo Makoto, Sugihara Eiji, Takeda Mayu, Nohara Sachio, Tanishima Shigeki, Takenaka Masashi, Zennami Kenji, Takahara Kiyoshi, Shiroki Ryoichi, Saya Hideyu |
| Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2024 12 51 (3): 109380. Quratul Ain, Rachel L O'Connell, Parinita Swarnkar, Terri McVeigh, Angela George, Marios K Tasoulis, Gerald Ph Gui, Jennifer Wiggins, Aadil A Khan, Katherine Dc Krupa, Peter A Barry, Susana Banerjee, Jennifer E Rus |
| Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohort. ESMO open 2024 12 10 (1): 104090. F Camarda, L Mastrantoni, C Parrillo, A Minucci, F Persiani, D Giannarelli, T Pasciuto, F Giacomini, E De Paolis, M Manfredelli, C Marchetti, G F Zannoni, A Fagotti, G Scambia, C Ne |
| Prognostic implications of ductal carcinoma in situ components in BRCA1/2-positive breast cancer: a retrospective cohort study. Annals of surgical treatment and research 2024 12 107 (6): 327-335. Kyung-Hwak Yoon, Eun-Kyu Kim, Hee-Chul Sh |
| Survival Outcomes and Genetic Characteristics of Resected Pancreatic Acinar Cell Carcinoma. Annals of surgical oncology 2024 11 . Alex B Blair, Shannon N Radomski, Joanne Chou, Mengyuan Liu, Thomas Clark Howell, Wungki Park, Eileen M O'Reilly, Lei Zheng, Vinod P Balachandran, Alice C Wei, T Peter Kingham, Michael I D'Angelica, Jeffrey Drebin, Sabino Zani, Dan G Blazer, Richard A Burkhart, William R Burns, Kelly J Lafaro, Peter J Allen, William R Jarnagin, Michael E Lidsky, Jin He, Kevin C Soar |
| CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
- Page last reviewed:Feb 1, 2024
- Content source: